Atlas Trials

SPY-X: A Study to Assess the Feasibility of Using SPY Alone for Sentinel Node Localization for Melanoma or Breast Cancer

Clinical trial NCT03294330 · COMPLETED

Trial details

NCT number
NCT03294330
Sponsor
Milton S. Hershey Medical Center
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Sentinel Lymph NodeMelanoma (Skin)Breast Cancer
Start date
2017-10-11
Primary completion
2021-09-17
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.